Literature DB >> 12949253

Cardiovascular autonomic dysfunction in primary Sjögren's syndrome.

László Kovács1, Dóra Paprika, Róbert Tákacs, Attila Kardos, Tamás T Várkonyi, Csaba Lengyel, Attila Kovács, László Rudas, Gyula Pokorny.   

Abstract

OBJECTIVE: To assess the occurrence and clinical significance of a cardiovascular autonomic nervous system dysfunction in primary Sjögren's syndrome (pSS).
METHODS: Fifty-one pSS patients participated in this case-control study. Heart rate and blood pressure variability measurements, spontaneous baroreflex sensitivity examinations and cardiovascular reflex tests were performed.
RESULTS: The results of the heart rate and blood pressure variability measurements and also the baroreflex sensitivity parameters of the pSS patients peaked in the lowest percentile ranges of a database on 559 healthy control subjects (P < 0.05). In three of the five cardiovascular reflex tests, the frequencies of abnormal results were significantly higher among the patients than among the controls (P < 0.05), and the median autonomic neuropathy score was also elevated (3 vs 0 in the controls; P < 0.0001).
CONCLUSION: Signs of an autonomic nervous system dysfunction involving the cardiovascular system can be discerned in the majority of pSS patients.

Entities:  

Mesh:

Year:  2003        PMID: 12949253     DOI: 10.1093/rheumatology/keg468

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

1.  Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure.

Authors:  W-F Ng; A J Stangroom; A Davidson; K Wilton; S Mitchell; J L Newton
Journal:  QJM       Date:  2012-09-13

Review 2.  Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research.

Authors:  Kristen Davies; Emma Dures; Wan-Fai Ng
Journal:  Nat Rev Rheumatol       Date:  2021-10-01       Impact factor: 20.543

3.  The Association Between Sjögren Syndrome and Adverse Postoperative Outcomes: A Historical Cohort Study Using Administrative Health Data.

Authors:  Rovnat Babazade; Zhuo Sun; Brian D Hesler; Arjun Sharma; Natalya Makarova; Jarrod E Dalton; Alparslan Turan
Journal:  Anesth Analg       Date:  2015-11       Impact factor: 5.108

4.  Autonomic dysfunction in primary Sjogren's syndrome: a prospective cohort analysis of 154 Korean patients.

Authors:  Jung Hee Koh; Seung-Ki Kwok; Jennifer Lee; Sung-Hwan Park
Journal:  Korean J Intern Med       Date:  2016-03-25       Impact factor: 2.884

Review 5.  Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.

Authors:  Péter Bencsik; Kamilla Gömöri; Tamara Szabados; Péter Sántha; Zsuzsanna Helyes; Gábor Jancsó; Péter Ferdinandy; Anikó Görbe
Journal:  Br J Pharmacol       Date:  2020-03-21       Impact factor: 8.739

Review 6.  Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome.

Authors:  Kristen Davies; Wan-Fai Ng
Journal:  Front Immunol       Date:  2021-07-26       Impact factor: 7.561

7.  Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.

Authors:  Julia L Newton; James Frith; Danielle Powell; Kate Hackett; Katharine Wilton; Simon Bowman; Elizabeth Price; Colin Pease; Jacqueline Andrews; Paul Emery; John Hunter; Monica Gupta; Saravanan Vadivelu; Ian Giles; David Isenberg; Peter Lanyon; Adrian Jones; Marian Regan; Annie Cooper; Robert Moots; Nurhan Sutcliffe; Michele Bombardieri; Costantino Pitzalis; John McLaren; Steven Young-Min; Bhaskar Dasgupta; Bridget Griffiths; Dennis Lendrem; Sheryl Mitchell; Wan-Fai Ng
Journal:  Ann Rheum Dis       Date:  2012-05-05       Impact factor: 19.103

8.  Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study.

Authors:  Fin Z J Cai; Sue Lester; Tim Lu; Helen Keen; Karyn Boundy; Susanna M Proudman; Anne Tonkin; Maureen Rischmueller
Journal:  Arthritis Res Ther       Date:  2008-03-07       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.